Sex-specific adverse drug effects identified by Columbia University algorithm
There is a paucity of real-world clinical data that evaluates adverse drug effects in women, among other underserved populations, due to a long history of trials done on relatively homogenous patient populations (healthy white males). Without heterogeneous data availability, biased results leave women in the dangerous position of not having accurate information on adverse drug…